A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390 · clinicaltrials.gov ↗

COMPLETED

Status

1041

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

OTHER: No drug

Sponsor

Daiichi Sankyo